Lei Z, Ouyang L, Gong Y, Wang Z, Yu B. Effect of Eriodictyol on Collagen-Induced Arthritis in Rats by Akt/HIF-1α Pathway.
Drug Des Devel Ther 2020;
14:1633-1639. [PMID:
32425508 PMCID:
PMC7196781 DOI:
10.2147/dddt.s239662]
[Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/22/2019] [Accepted: 02/25/2020] [Indexed: 12/13/2022]
Abstract
Purpose
The aim of the experiment was to explore the effect of eriodictyol (ERI) on arthritis.
Methods
We established a rat model of collagen-induced rheumatoid arthritis (CIA) using type II collagen plus Freund’s complete adjuvant. We evaluated the degree of paw swelling, joint pathology, inflammatory cytokine levels, and the Akt/hypoxia-inducible factor (HIF)-1α signaling pathway in the CIA rats.
Results
ERI significantly ameliorated joint swelling; improved joint pathology; and suppressed the release of interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha. Moreover, ERI inhibited the Akt/HIF-1α pathway in the joints of rats and in lipopolysaccharide-treated RAW264.7 cells.
Conclusion
ERI ameliorated arthritis in a manner involving the Akt/HIF-1α signaling pathway.
Collapse